Retatrutide/Tirzepatide

Weight Loss

4Vendors

Speculative stack for people chasing extreme multi-pathway weight loss. Real-world interest exists, but evidence for using both together is thin and largely forum- or vendor-led.

View Vendors

Studies
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.	PubMed
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.	PubMed
Tirzepatide Once Weekly for the Treatment of Obesity.	PubMed

Retatrutide/Tirzepatide Vendors
Flawless Compounds 0.0	Profile
Glacier Aminos 0.0	Profile
Glow Aminos 0.0	Profile
Southern Aminos 0.0	Profile

Retatrutide/Tirzepatide Vendors